Checkpoint immunotherapy for NK/T cell lymphoma-Time for a showdown?

Precis Clin Med

Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, 169610, Singapore.

Published: March 2021

A commentary on "Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma".

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982608PMC
http://dx.doi.org/10.1093/pcmedi/pbab004DOI Listing

Publication Analysis

Top Keywords

checkpoint immunotherapy
4
immunotherapy nk/t
4
nk/t cell
4
cell lymphoma-time
4
lymphoma-time showdown?
4
showdown? commentary
4
commentary "combination
4
"combination anti-pd-1
4
anti-pd-1 antibody
4
antibody p-gemox
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!